Ireland doesn’t have its own separate approval system for medical devices. Instead, Ireland Medical Device Regulations sit within the EU framework, built primarily around Regulation (EU) 2017/745 (EU MDR) and Regulation (EU) 2017/746 (EU IVDR). On top of that there is one more layer, national registration, administered by the Health Products Regulatory Authority (HPRA).
It’s worth being clear on this distinction early. CE marking is not the same action as HPRA registration or notification, and manufacturers who assume otherwise tend to run into delays that could have been avoided.
This article walks through the full Ireland Medical Device Registration Process from classification to post-market surveillance.
Regulatory Authorities for Medical Devices in Ireland
Two levels of authority matter here. The European Commission owns the legislation. HPRA administers it domestically and runs the additional Irish national layer.
Health Products Regulatory Authority (HPRA)
HPRA is Ireland’s competent authority for medical devices and IVDs. Its role includes:
- Validating EUDAMED registration applications from Irish-based manufacturers, authorised representatives, importers and system/procedure pack producers (organisations that combine CE-marked devices into a kit or pack for a specific medical purpose)
- Running the purely national registration route for Irish-based distributors and manufacturing facilities
- Operating Ireland’s device vigilance system, which evaluates safety reports from manufacturers, users, and other stakeholders
- Receiving reports of serious risk or falsified devices from importers and distributors
- Carrying out market surveillance and inspections of manufacturers and manufacturing facilities established in Ireland
European Commission
The Commission is the author of the MDR and IVDR texts and owns EUDAMED, the EU’s central device database. It also issues guidance through the Medical Device Coordination Group (MDCG), which member state authorities including HPRA reference when interpreting the Regulations.
Ireland Medical Device Classification
Ireland does not maintain a separate national classification scheme. Ireland Medical Device Classification follows the same risk-based system set out under MDR Annex VIII, the same rules every other EU member state applies.
Devices fall into one of four classes:
- Class I – lowest risk
- Class IIa – low to medium risk
- Class IIb – medium to high risk
- Class III – highest risk
Class matters because it decides how much external checking a device needs. Self-declaration is available for most Class I devices. Everything from Class IIa upward generally requires assessment by a Notified Body before the CE mark can be applied, with the depth of technical documentation and post-market obligations scaling up with risk class.
Authorized Representative (EC REP) Requirements in Ireland
If a manufacturer is not established in the EU, it must appoint an EU Authorised Representative before placing a device on any EU market, Ireland included. This obligation comes from MDR Article 11.
The Authorised Representative:
- Acts under a written mandate from the manufacturer, per MDR Article 11
- Keeps technical documentation and the EU Declaration of Conformity available for competent authorities
- Serves as the EU contact point for regulatory correspondence
- Cooperates on vigilance and corrective action matters, as per obligations described in MDR Article 13
Basing the Authorised Representative in Ireland is optional, not a legal requirement. The EC REP obligation applies EU-wide, so the representative can be established in any EU member state, not only Ireland. If the manufacturer does choose an Ireland-based EC REP, that registration gets validated by HPRA through EUDAMED.
Medical Device Regulatory Guidelines in Ireland
Manufacturers preparing for Irish market entry should treat these, in order of authority, as the reference sources:
- Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR) where applicable
- European Commission medical device guidance and MDCG guidance documents
- S.I. 691/2021 and S.I. 365/2022, Ireland’s national registration regulations
- HPRA guidance pages covering registration and vigilance
Ireland operates inside the EU system for the substantive safety and performance requirements. The additional Irish layer is narrower, focused on registration of Irish-established entities and on notification obligations.
Medical Device Registration Process in Ireland
CE marking and Irish registration or notification are not automatically the same regulatory action. A device can be validly CE marked under the MDR while the organisation placing it on the Irish market still has a separate HPRA registration or notification obligation to complete, depending on its role.
Step 1: Determine the device classification. Work through MDR Annex VIII to confirm class before anything else is built.
Step 2: Confirm the product qualifies as a medical device under the applicable EU definition and identify which regulation (MDR or IVDR) applies.
Step 3: Establish the Quality Management System, typically built around ISO 13485. This needs to be operating before technical documentation is finalised, not treated as a later checkbox. MDR Article 10 requires the QMS to cover the device’s full lifecycle.
Step 4: Prepare technical documentation as per MDR Annex II and Annex III, built under that QMS.
Step 5: Complete clinical evaluation under MDR Article 61 and Annex XIV, feeding into the technical documentation above.
Step 6: Complete the appropriate conformity assessment, using the technical documentation and clinical evaluation built in the previous steps. Self-declaration is available for most Class I devices; higher classes require Notified Body involvement under MDR Annex IX, X, or XI.
Step 7: Appoint a Person Responsible for Regulatory Compliance (PRRC). This is an EU-level requirement under MDR Article 15, applying to every manufacturer regardless of where in the EU the device is placed, Ireland included.
The PRRC must hold specified qualifications (a relevant degree plus at least one year of regulatory or QMS experience, or four years of relevant professional experience in its absence) and is responsible for checking device conformity before release, maintaining technical documentation and the Declaration of Conformity, and overseeing PMS and vigilance reporting obligations.
Micro and small manufacturers are exempt from employing an internal PRRC and may contract this role externally instead. Where a manufacturer is based outside the EU, its Authorised Representative must also have its own, separate PRRC.
Step 8: Appoint an EU Authorised Representative if the manufacturer is based outside the EU.
Step 9: Complete the applicable Irish registration or notification. This step is where the roles matter most, so it’s worth being precise. Based on current HPRA guidance:
- Manufacturers and authorised representatives established in Ireland, along with their non-EU manufacturers, importers and system/procedure pack producers, register through EUDAMED, and HPRA validates that application, issuing a Single Registration Number (SRN)
- Distributors established in Ireland register directly and nationally with HPRA, not via EUDAMED
- Manufacturing facilities based in Ireland also register nationally with HPRA
- Manufacturers of custom-made devices register their organisation and device details via EUDAMED for Class III custom-made and implantable devices; for Class I, IIa, and IIb custom-made devices, HPRA guidance directs registration through HPRA’s own national online form instead
- Health institutions manufacturing and using in-house devices or IVDs (devices made and used within the same institution, not placed on the open market) have a separate notification obligation under S.I. 691/2021 and S.I. 365/2022: they must identify themselves to HPRA and be able to supply device information on request, including a public declaration required.
- Manufacturers based in other EU member states who have already registered via EUDAMED do not need to register separately with HPRA to place products on the Irish market
Do not assume every device or every economic operator needs to register directly with HPRA. The route depends on the specific role, device type and where the entity is established.
Step 10: Meet Irish labelling and language requirements
Step 11: Place the device on the Irish market, with manufacturer, importer and distributor obligations under MDR Articles 10-16 all remaining active.
Step 12: Maintain post-market surveillance and vigilance for the life of the device on the Irish market.
Required Documents for Medical Device Registration in Ireland
Manufacturers often lump every document into one pile and assume it all goes to HPRA. It doesn’t. The table below separates documents by what they’re actually for.
| Document | Purpose |
| EU Declaration of Conformity | Demonstrates MDR conformity |
| CE certificate (where a Notified Body was involved) | Demonstrates MDR conformity |
| Technical documentation (MDR Annex II and III) | Demonstrates MDR conformity |
| Clinical Evaluation Report and risk management documentation | Demonstrates MDR conformity |
| QMS documentation | Demonstrates MDR conformity |
| PRRC designation and qualification records | Demonstrates MDR conformity |
| Economic operator details | Registration record |
| Authorised Representative mandate, where applicable | Registration record |
| Device and UDI information | Registration record |
| PMS documentation | Ongoing compliance record |
| Vigilance records and incident reports | Ongoing compliance record |
| Updated technical files reflecting device changes | Ongoing compliance record |
Not every document here is submitted to HPRA as a matter of course. HPRA’s own guidance on manufacturer registration makes clear that registration is mainly about registering the organisation and device details.
QMS Requirements for Medical Devices in Ireland
The Quality Management System (QMS) obligation in Ireland comes from MDR Article 10, which requires manufacturers to operate a quality management system proportionate to the device’s risk class, covering design controls, supplier management, production controls, complaint handling, CAPA and post-market surveillance.
ISO 13485 is the standard most manufacturers use to demonstrate this in practice. It is widely relied upon by Notified Bodies during conformity assessment under MDR Annex IX, but it isn’t automatically a stand-alone legal requirement for every device.
A Class I self-declaring manufacturer, for example, is not legally required to hold third-party ISO 13485 certification, even though many choose to.
Medical Device Labelling Requirements in Ireland
Ireland Medical Device Labelling Requirements start with the substantive MDR content, then add the language layer.
Ireland follows the same MDR labelling content rules as any other EU market. A label needs to include the CE mark, the manufacturer’s identity and address, the Authorised Representative’s details for non-EU manufacturers, UDI, a batch or serial number, warnings and precautions, and the Instructions for Use. These requirements come from a few different parts of the MDR. Article 10(11) covers the language the label must use, Article 20 covers the CE mark itself, Article 27 covers where the UDI carrier goes and Annex I sets out the general requirements.
For Ireland, the language rule comes from S.I. No. 547/2017. Labels, Instructions for Use, and related documents must be in English. Irish can be added on top, but it’s optional, not required.
Registration Timelines for Medical Devices in Ireland
The available official Irish and EU sources do not specify a single standardised end-to-end timeline for the full Ireland Medical Device Registration Timeline, because so much of it depends on classification, Notified Body queue times, and how complete the submission is.
The one figure HPRA does publish, the 10-working-day processing window for registration applications once submitted, applies specifically to that registration step, not to CE marking or Notified Body review as a whole.
Medical Device Registration Costs in Ireland
HPRA confirms that there is an annual maintenance fee for all registered economic operators, based on the registration information held both directly and via EUDAMED, with invoices issued in the second quarter of each year. Entities that register directly with HPRA rather than via EUDAMED, such as distributors and manufacturing facilities, also pay an additional administration fee, which must be received before registration is confirmed.
Specific fee amounts and codes are set out in HPRA’s own fee schedule and application form, and these are reviewed and adjusted periodically. This requirement should be confirmed against the current guidance published by HPRA before market entry, using the resources below
Beyond the HPRA fee itself, manufacturers should budget separately for Notified Body fees, testing costs, clinical evaluation work, QMS certification, translation and regulatory consulting support.
Import Requirements for Medical Devices in Ireland
Ireland Medical Device Import Requirements split into two distinct categories that shouldn’t be merged: medical device regulatory obligations and general customs procedures.
On the regulatory side, importers under MDR Article 13 must verify that the device carries a valid CE mark, that a Declaration of Conformity exists, that the manufacturer has appointed an EU Authorised Representative where required and that labelling meets MDR requirements before placing the device on the Irish market. Importers established in Ireland register their organisation via EUDAMED, and following validation, HPRA contacts registered importers directly for further information on the specific devices being imported.
Distributors, by contrast, register nationally and directly with HPRA rather than through EUDAMED, using HPRA’s own online registration form.
On the customs side, general import procedures, tariff classification and VAT treatment sit with Revenue, the Irish tax and customs authority, and are separate from the device-specific MDR obligations above. Revenue’s own guidance confirms that relief from Customs Duty is available for certain medical instruments and apparatus imported from outside the EU, though VAT remains payable regardless.
Post-Market Surveillance (PMS) Requirements in Ireland
Ireland Medical Device Post-Market Surveillance is not a one-time task tied to CE marking. It’s an ongoing manufacturer obligation under MDR Articles 83-92 that continues for as long as the device remains on the Irish market.
This covers a PMS system and PMS plan proportionate to device risk, PMS reports for Class I devices, Periodic Safety Update Reports (PSURs) for higher-risk classes and ongoing trend analysis of complaints and field data.
For vigilance specifically, HPRA operates Ireland’s device vigilance system and is the point of contact for serious incident and safety concern reporting. Where an importer or distributor in Ireland suspects a device presents a serious risk or is falsified, HPRA’s guidance directs them to notify HPRA immediately by email at devicesafety@hpra.ie.
Reporting timelines and formats for serious incidents and Field Safety Corrective Actions (FSCAs) follow the MDR’s Chapter VII vigilance framework.
Conclusion
Ireland works inside the EU MDR and IVDR system, not a separate national approval process. CE marking is still what gets a device to market, but the Irish-specific layer, HPRA registration by role, English labelling and ongoing vigilance engagement, needs to be checked against current HPRA and EU sources before entry, not assumed from another member state.
If you need support with medical device registration, CE marking, technical documentation, HPRA requirements, or Irish market entry, reach out to the experts at info@artixio.com for guidance tailored to your product and market entry goals.
FAQs
Q1. Is medical device registration required in Ireland?
It depends on the organisation’s role and where it’s established. Manufacturers and authorised representatives established in Ireland register via EUDAMED, which HPRA validates. Distributors and manufacturing facilities established in Ireland register directly and nationally with HPRA. Manufacturers already registered via EUDAMED in another EU member state don’t need to register separately with HPRA to sell into Ireland.
Q2. Does Ireland require CE marking for medical devices?
Yes. CE marking under the applicable EU MDR or IVDR conformity assessment route is required before a device can be placed on the Irish market, as it is across the EU.
Q3. What is HPRA’s role in medical device registration?
HPRA validates EUDAMED registration applications from Irish-based manufacturers, authorised representatives, importers, and system/procedure pack producers, and runs the fully national registration route for Irish-based distributors and manufacturing facilities. It also operates Ireland’s vigilance and market surveillance system.
Q4. Are medical device labels required in Irish?
No, not exclusively. Per S.I. No. 547/2017 and the European Commission’s compiled national language requirements table, Ireland’s rule is “English language, or English language and Irish language.” English on its own is sufficient; Irish can be added but isn’t mandatory.
Q5. How long does Medical Device Registration in Ireland take?
HPRA processes EUDAMED and national registration applications within 10 working days once submitted. There’s no single published timeline for the full process, since CE marking preparation and any Notified Body review beforehand depend on device classification and documentation readiness.
